ASCERTAIN

ASCERTAIN (Affordability and Sustainability improvements through new pricing, Cost- Effectiveness and ReimbursemenT models to Appraise INnovative health technologies) addresses the need of patients, physicians, payers, regulators, and manufacturers to improve the affordability and accessibility to innovative health technologies (including pharmaceuticals) in Europe.

ASCERTAIN, will co-create and develop a cloud-based publicly accessible ASCERTAIN policy support tool for decision-makers to improve access to IHTs, including medicines. It will include new models (pricing, (cost-)effectiveness, and reimbursement).